Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Immunol.

Sec. Inflammation

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1613603

Combined Complement and Coagulation Activation in ST-Elevation Myocardial Infarction: Associations with myocardial injury and dysfunction

Provisionally accepted
Karsten  Engseth KlugeKarsten Engseth Kluge1,2*Sigrun  HalvorsenSigrun Halvorsen1,2Geir  Øystein AndersenGeir Øystein Andersen2Charlotte  Holst HansenCharlotte Holst Hansen2Ingebjørg  SeljeflotIngebjørg Seljeflot2Theis  TønnessenTheis Tønnessen1,3Ida  Gjervold LundeIda Gjervold Lunde1,2,4Ragnhild  HelsethRagnhild Helseth2
  • 1University of Oslo, Oslo, Norway
  • 2Oslo Center for Clinical Heart Research, Department of Cardiology, Oslo University Hospital Ullevål, Oslo, Norway
  • 3Department of Cardiothoracic Surgery, Oslo University Hospital, Oslo, Norway
  • 4KG Jebsen Center for Cardiac Biomarkers, Campus Ahus, University of Oslo, Oslo, Norway

The final, formatted version of the article will be published soon.

Introduction: Preclinical data indicates reciprocal activation of the complement system and the coagulation cascade. The magnitude of this interaction in patients with acute myocardial infarction is unknown. We aimed to determine associations between circulating markers of complement and coagulation activation in patients with acute ST-elevation myocardial infarction (STEMI), and explore a possible link to myocardial injury and left ventricular dysfunction. Materials and methods: We included 864 patients with STEMI. Blood was drawn at a median of 18 hours after percutaneous coronary intervention. Complement activation was assessed by the terminal complement complex (TCC), and coagulation activation by prothrombin fragment 1+2 (F1+2), D-dimer and endogenous thrombin potential (ETP). Myocardial injury was estimated by peak troponin T (TnT), and left ventricular function was quantified on echocardiography by left ventricular ejection fraction (LVEF). Results: TCC was weakly correlated to F1+2 (r=0.086, p=0.012), D-dimer (r=0.176, p<0.001) and ETP (r=0.144, p<0.001). In multivariate binary logistic regression, there was no significant interaction between TCC and the coagulation markers on the risk of having high peak TnT or low LVEF. Conclusion: In this STEMI cohort, complement activation as measured by TCC was weakly associated with markers of coagulation activation, but the two systemsmeasured markers had no combined relation with the risk of high peak TnT or low LVEF. These findings suggest that while simultaneous activation of complement and coagulation cannot be ruled out, combined high levels of TCC and coagulation markers do not mirror simultaneous high activation of both systems is not relevant for the extent of myocardial injury or dysfunction in STEMI.

Keywords: complement system, coagulation system, STEMI, Coronary Artery Disease, Revascularization, Heart Failure

Received: 17 Apr 2025; Accepted: 20 Oct 2025.

Copyright: © 2025 Kluge, Halvorsen, Andersen, Hansen, Seljeflot, Tønnessen, Lunde and Helseth. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Karsten Engseth Kluge, karstenek@gmail.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.